The Food and Drug Administration said that it will require stricter labeling of drugs containing propoxyphene, such as Darvon, which the European Union"s FDA equivalent , has phased out. The agency requires makers to add a boxed warning about the risk of fatal overdoses and further studies will be done on the effect of the drug on patients" heart function. The study will focus on how often elderly patients are prescribed propoxyphene compared with other pain relievers. The FDA received 91 reports of deaths linked to the medicine from 1969 to 2005. Most are related to overdoses and suicide attempts.
저작권자 © 메디칼업저버 무단전재 및 재배포 금지